极早期检出与单灶肝细胞癌患者生存改善相关
这项多中心回顾性研究纳入140例单灶肝细胞癌(HCC)患者,比较T1a与T1b期的生存差异。T1a组中位总生存为5.5年,T1b组为3.1年(p=0.019)。多因素分析显示Child-Pugh B级、较高AFP对数值和病灶大小与死亡风险增加相关。
要点
- T1a期HCC检出较T1b期带来生存优势,中位总生存5.5年对3.1年。
- Child-Pugh B级、较高AFP对数值和病灶大小是死亡的独立相关因素。
- 结果支持持续改进HCC监测效能以促进极早期检出。
核心结论
- T1a期检出HCC较T1b期具有生存优势,提示仍需改进HCC监测效能。
主要发现
- 140例患者中88例为T1a期,52例为T1b期,中位年龄67岁,男性占72%。
- T1a期患者中位总生存为5.5年(95%CI:3.79-不可评估),T1b期为3.1年(95%CI:2.52-4.63),p=0.019。
- 多因素分析中,死亡与Child-Pugh B级(对比A级;HR:2.362;95%CI:1.39-4.93)、较高AFP对数值(HR:1.42;95%CI:1.20-1.69)和病灶大小(每cm;HR:2.95;95%CI:1.69-5.16)显著相关。
临床怎么用
- 对肝硬化患者坚持HCC监测,力求在T1a期检出单灶HCC以改善生存。
- 评估预后时关注Child-Pugh分级、AFP水平和病灶大小。
局限性
- 回顾性设计可能存在选择偏倚。
- 样本量较小(140例),仅来自美国三个中心。
- 仅纳入Child-Pugh A或B级且90天内及时治疗的患者,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The goal of hepatocellular carcinoma (HCC) surveillance is to improve early HCC detection; however, the incremental benefits of detection of T1a tumours compared to T1b tumours are unclear. We aimed to evaluate the survival of patients with HCC detected at a T1a stage compared to T1b stage. METHODS: We conducted a multicentre retrospective study of adult patients from three sites in the United States who were newly diagnosed with unifocal HCC (based on LIRADS v2018), measuring between 1.0 and 3.0 cm at diagnosis between July 2013 and November 2022. All patients were required to have Child-Turcotte-Pugh (CP) class A or B cirrhosis and undergo timely treatment within 90 days of diagnosis. Multivariable Cox proportional hazard models were used to evaluate associations between tumour size (T1a vs. T1b) and overall survival and transplant-free survival. RESULTS: Of 140 eligible patients (median age 67 years, 72% male), 88 had T1a and 52 had T1b HCC. Median overall survival was 5.5 (95% CI: 3.79-NE (Not Evaluable)) years for patients with T1a HCC versus 3.1 (95% CI: 2.52-4.63) years for those with T1b HCC (p = 0.019). In multivariable analysis, mortality was significantly associated with Child Pugh B (vs. Child Pugh A; HR: 2.362; 95% CI: 1.39-4.93), higher logarithm transformed AFP (HR: 1.42; 95% CI: 1.20-1.69) and lesion size in cm (HR: 2.95; 95% CI: 1.69-5.16). CONCLUSIONS: Detection of HCC at a T1a stage conveys a survival advantage compared to T1b stage, underscoring a continued need for improvements in HCC surveillance efficacy.
引用
- Hunold T, Seif El Dahan K, Pai S, et al. Very Early-Stage Detection Is Associated With Improved Survival in Patients With Unifocal Hepatocellular Carcinoma. Aliment Pharmacol Ther. 2025. PMID: 41173809. doi:10.1111/apt.70438
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。